Investigational Site Number 8925

New York, New York 10029-6574

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis — Completed